Medicenna Therapeutics Corp.

MDNA.TOTSXHealthcare● Active

$0.44

$-0.02(-3.33%)

Market Cap$29900726

P/E Ratio—

52W High$1.97

52W Low$0.41

Avg Volume116K

Open$0.43

Beta1.85

Cash on Hand Financials Revenue

Medicenna Therapeutics Corp. (MDNA.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDNA.TO · cash on hand · updated Mar 31, 2025

Core cash position

as of Mar 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$24.8M▲ +46.3% vs prior year

FY · as of Mar 31, 2025 · Reported in CAD

Cash & Cash Equiv. (CCE)

$24.8M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+46.3%

vs prior fiscal year

Latest Quarter

$10.6M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$24.8MCash on Hand

Total Debt$168,000Total Debt

Net Cash / Net Debt+$24.7MNet Cash Position

Cash vs Debt Ratio

Cash 99%Medicenna Therapeutics Corp. cash as % of market cap: 83.06%% · MCap $0BDebt 1%

Medicenna Therapeutics Corp. has a net cash position of $24.7M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$24.8M − $168,000 = +$24.7M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

MDNA.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

MDNA.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Mar 31, 2025LatestFY$24.8M+46.3%

Mar 31, 2024FY$17.0M-49.5%

Mar 31, 2023FY$33.6M+63.6%

Mar 31, 2022FY$20.5M-49.2%

Mar 31, 2021FY$40.4M+7.1%

MDNA.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

MDNA.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Medicenna Therapeutics Corp.YOU

MDNA.TO

$24.8M$30M83.1%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Medicenna Therapeutics Corp. (MDNA.TO) cash on hand as of March 31, 2025 is $24.8M, comprising $24.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Medicenna Therapeutics Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Medicenna Therapeutics Corp. cash reserves or cash position.

Medicenna Therapeutics Corp. annual cash on hand history shows increased +46.3% in 2025: increased +46.3% in 2025. Medicenna Therapeutics Corp. cash reserves in 2025 reflect the company's capital allocation strategy.

Medicenna Therapeutics Corp. carries total debt of $168,000 against cash of $24.8M, resulting in a net cash position of +$24.7M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

MDNA.TO cash on hand · 5 questions

As of March 31, 2025, Medicenna Therapeutics Corp. (MDNA.TO) has $24,837,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $24,837,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $10,614,000. Data sourced from the annual 10-K filing via FMP.

MDNA.TO cash on handMDNA.TO cash reservesMDNA.TO cash 2025how much cash does MDNA.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Medicenna Therapeutics Corp. · Medicenna Therapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2025